- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Transdermal Patch market will register a 1.5% CAGR in terms of revenue, the global market size will reach $ 7779.8 million by 2025, from $ 7343.8 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Transdermal Patch business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Patch market by type, application, key manufacturers and key regions and countries.
This study considers the Transdermal Patch value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Estradiol Transdermal Patch
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Relieve Pain
Smoking Stopping
Cardiovascular Diseases
Menopausal Syndrome
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Hisamitsu Pharmaceutical
Pfizer
Johnson & Johnson
UCB Pharma
Mylan
Novartis
GSK
Nitto Denko
Luye Pharma Group
Teikoku Seiyaku
Beijing Tide Pharmaceutical
Teva Pharmaceutical
Mundipharma
Bayer
Lohmann Therapie-Systeme
Dr Reddy’s Laboratories
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Transdermal Patch consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Transdermal Patch market by identifying its various subsegments.
Focuses on the key global Transdermal Patch manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Transdermal Patch with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Transdermal Patch submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transdermal Patch Consumption 2015-2025
2.1.2 Transdermal Patch Consumption CAGR by Region
2.2 Transdermal Patch Segment by Type
2.2.1 Methyl Salicylate-based Patch
2.2.2 Rivastigmine Transdermal Patch
2.2.3 Fentanyl Transdermal Patch
2.2.4 Nicotine Transdermal Patch
2.2.5 Estradiol Transdermal Patch
2.2.6 Others
2.3 Transdermal Patch Consumption by Type
2.3.1 Global Transdermal Patch Consumption Market Share by Type (2015-2020)
2.3.2 Global Transdermal Patch Revenue and Market Share by Type (2015-2020)
2.3.3 Global Transdermal Patch Sale Price by Type (2015-2020)
2.4 Transdermal Patch Segment by Application
2.4.1 Relieve Pain
2.4.2 Smoking Stopping
2.4.3 Cardiovascular Diseases
2.4.4 Menopausal Syndrome
2.4.5 Others
2.5 Transdermal Patch Consumption by Application
2.5.1 Global Transdermal Patch Consumption Market Share by Type (2015-2020)
2.5.2 Global Transdermal Patch Value and Market Share by Type (2015-2020)
2.5.3 Global Transdermal Patch Sale Price by Type (2015-2020)
3 Global Transdermal Patch by Company
3.1 Global Transdermal Patch Sales Market Share by Company
3.1.1 Global Transdermal Patch Sales by Company (2018-2020)
3.1.2 Global Transdermal Patch Sales Market Share by Company (2018-2020)
3.2 Global Transdermal Patch Revenue Market Share by Company
3.2.1 Global Transdermal Patch Revenue by Company (2018-2020)
3.2.2 Global Transdermal Patch Revenue Market Share by Company (2018-2020)
3.3 Global Transdermal Patch Sale Price by Company
3.4 Global Transdermal Patch Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Transdermal Patch Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Transdermal Patch Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Transdermal Patch by Regions
4.1 Transdermal Patch by Regions
4.2 Americas Transdermal Patch Consumption Growth
4.3 APAC Transdermal Patch Consumption Growth
4.4 Europe Transdermal Patch Consumption Growth
4.5 Middle East & Africa Transdermal Patch Consumption Growth
5 Americas
5.1 Americas Transdermal Patch Consumption by Countries
5.1.1 Americas Transdermal Patch Consumption by Countries (2015-2020)
5.1.2 Americas Transdermal Patch Value by Countries (2015-2020)
5.2 Americas Transdermal Patch Consumption by Type
5.3 Americas Transdermal Patch Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Transdermal Patch Consumption by Regions
6.1.1 APAC Transdermal Patch Consumption by Regions (2015-2020)
6.1.2 APAC Transdermal Patch Value by Regions (2015-2020)
6.2 APAC Transdermal Patch Consumption by Type
6.3 APAC Transdermal Patch Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Transdermal Patch by Countries
7.1.1 Europe Transdermal Patch Consumption by Countries (2015-2020)
7.1.2 Europe Transdermal Patch Value by Countries (2015-2020)
7.2 Europe Transdermal Patch Consumption by Type
7.3 Europe Transdermal Patch Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Transdermal Patch by Countries
8.1.1 Middle East & Africa Transdermal Patch Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Transdermal Patch Value by Countries (2015-2020)
8.2 Middle East & Africa Transdermal Patch Consumption by Type
8.3 Middle East & Africa Transdermal Patch Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Transdermal Patch Distributors
10.3 Transdermal Patch Customer
11 Global Transdermal Patch Market Forecast
11.1 Global Transdermal Patch Consumption Forecast (2021-2025)
11.2 Global Transdermal Patch Forecast by Regions
11.2.1 Global Transdermal Patch Forecast by Regions (2021-2025)
11.2.2 Global Transdermal Patch Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Transdermal Patch Forecast by Type
11.8 Global Transdermal Patch Forecast by Application
12 Key Players Analysis
12.1 Hisamitsu Pharmaceutical
12.1.1 Company Information
12.1.2 Transdermal Patch Product Offered
12.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Hisamitsu Pharmaceutical Latest Developments
12.2 Pfizer
12.2.1 Company Information
12.2.2 Transdermal Patch Product Offered
12.2.3 Pfizer Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Pfizer Latest Developments
12.3 Johnson & Johnson
12.3.1 Company Information
12.3.2 Transdermal Patch Product Offered
12.3.3 Johnson & Johnson Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Johnson & Johnson Latest Developments
12.4 UCB Pharma
12.4.1 Company Information
12.4.2 Transdermal Patch Product Offered
12.4.3 UCB Pharma Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 UCB Pharma Latest Developments
12.5 Mylan
12.5.1 Company Information
12.5.2 Transdermal Patch Product Offered
12.5.3 Mylan Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Mylan Latest Developments
12.6 Novartis
12.6.1 Company Information
12.6.2 Transdermal Patch Product Offered
12.6.3 Novartis Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Novartis Latest Developments
12.7 GSK
12.7.1 Company Information
12.7.2 Transdermal Patch Product Offered
12.7.3 GSK Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 GSK Latest Developments
12.8 Nitto Denko
12.8.1 Company Information
12.8.2 Transdermal Patch Product Offered
12.8.3 Nitto Denko Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Nitto Denko Latest Developments
12.9 Luye Pharma Group
12.9.1 Company Information
12.9.2 Transdermal Patch Product Offered
12.9.3 Luye Pharma Group Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Luye Pharma Group Latest Developments
12.10 Teikoku Seiyaku
12.10.1 Company Information
12.10.2 Transdermal Patch Product Offered
12.10.3 Teikoku Seiyaku Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Teikoku Seiyaku Latest Developments
12.11 Beijing Tide Pharmaceutical
12.11.1 Company Information
12.11.2 Transdermal Patch Product Offered
12.11.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Beijing Tide Pharmaceutical Latest Developments
12.12 Teva Pharmaceutical
12.12.1 Company Information
12.12.2 Transdermal Patch Product Offered
12.12.3 Teva Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Teva Pharmaceutical Latest Developments
12.13 Mundipharma
12.13.1 Company Information
12.13.2 Transdermal Patch Product Offered
12.13.3 Mundipharma Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Mundipharma Latest Developments
12.14 Bayer
12.14.1 Company Information
12.14.2 Transdermal Patch Product Offered
12.14.3 Bayer Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Bayer Latest Developments
12.15 Lohmann Therapie-Systeme
12.15.1 Company Information
12.15.2 Transdermal Patch Product Offered
12.15.3 Lohmann Therapie-Systeme Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Lohmann Therapie-Systeme Latest Developments
12.16 Dr Reddy’s Laboratories
12.16.1 Company Information
12.16.2 Transdermal Patch Product Offered
12.16.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Dr Reddy’s Laboratories Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Transdermal Patch Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of M
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
